Routine Donor Screening Revealed Acute Usutu Virus
By LabMedica International staff writers Posted on 20 Apr 2017 |

Image: The cobas TaqScreen WNV test: a real-time polymerase chain reaction (PCR) test to detect West Nile virus (WNV) RNA in plasma from blood, organ and tissue donor (Photo courtesy of Roche Diagnostics).
Usutu virus (USUV) an Old World flavivirus included in the Japanese encephalitis virus (JEV) antigenic complex is transmitted by mosquitoes to birds that act as the main amplifying hosts, while humans are considered incidental or dead-end hosts.
USUV can cause Usutu fever in humans with mild to severe symptoms characterized by fever, rash, jaundice, headache, nuchal rigidity, hand tremor, and hyperreflexia. Humans were considered incidental hosts with very low prevalence, but recent data from Italy indicated that human USUV infection may not be a sporadic event and is more frequent than West Nile Virus (WNV).
Scientists at the Bernhard Nocht Institute for Tropical Medicine and their colleagues followed up blood donors being routinely screened for WNV between 1 June and 31 December 2016. There were 13,023 blood donations from the University Hospital Aachen.
In a plasma pool of 16 donors, the scientists detected WNV-positive (threshold cycle, Ct: 40.5) using cobas TaqScreen WNV Test with a sensitivity of 206.4 copies/mL per single donation. The blood donor was a German woman in her late 20s, without any travel history outside Germany in the previous seven months. Furthermore, she had not left the Aachen region at all in the three months prior to blood donation. The healthy donor had not experienced any illness or symptoms in the six weeks before donation. She reported several mosquito bites before the donation.
The team extracted RNA of plasma and urine samples were tested for the presence of flavivirus RNA with pan-flavivirus real-time reverse transcription–polymerase chain reaction (RT-PCR). A positive PCR result was obtained with RNA from the plasma sample and direct Sanger sequencing of the PCR amplicon showed USUV nucleic acid sequence. Attempts to isolate USUV in cell culture using the donor plasma were not successful.
The concentrated and purified RNA was further subjected to deep sequencing using in-house next-generation sequencing pipeline in order to obtain larger fragments of the USUV genome. Thus, the scientists were able to successfully recover about 60% of the USUV polyprotein gene. USUV from the donor plasma showed 99% homology with those found in the birds during the 2016 epizootics corresponding with the same region from where the donor originated.
The authors concluded that during the ongoing USUV epizootics in Germany, blood transfusion services, public health authorities and clinicians should be aware of increased human USUV infections. The study was published on April 6, 2017, in the journal Eurosurveillance.
USUV can cause Usutu fever in humans with mild to severe symptoms characterized by fever, rash, jaundice, headache, nuchal rigidity, hand tremor, and hyperreflexia. Humans were considered incidental hosts with very low prevalence, but recent data from Italy indicated that human USUV infection may not be a sporadic event and is more frequent than West Nile Virus (WNV).
Scientists at the Bernhard Nocht Institute for Tropical Medicine and their colleagues followed up blood donors being routinely screened for WNV between 1 June and 31 December 2016. There were 13,023 blood donations from the University Hospital Aachen.
In a plasma pool of 16 donors, the scientists detected WNV-positive (threshold cycle, Ct: 40.5) using cobas TaqScreen WNV Test with a sensitivity of 206.4 copies/mL per single donation. The blood donor was a German woman in her late 20s, without any travel history outside Germany in the previous seven months. Furthermore, she had not left the Aachen region at all in the three months prior to blood donation. The healthy donor had not experienced any illness or symptoms in the six weeks before donation. She reported several mosquito bites before the donation.
The team extracted RNA of plasma and urine samples were tested for the presence of flavivirus RNA with pan-flavivirus real-time reverse transcription–polymerase chain reaction (RT-PCR). A positive PCR result was obtained with RNA from the plasma sample and direct Sanger sequencing of the PCR amplicon showed USUV nucleic acid sequence. Attempts to isolate USUV in cell culture using the donor plasma were not successful.
The concentrated and purified RNA was further subjected to deep sequencing using in-house next-generation sequencing pipeline in order to obtain larger fragments of the USUV genome. Thus, the scientists were able to successfully recover about 60% of the USUV polyprotein gene. USUV from the donor plasma showed 99% homology with those found in the birds during the 2016 epizootics corresponding with the same region from where the donor originated.
The authors concluded that during the ongoing USUV epizootics in Germany, blood transfusion services, public health authorities and clinicians should be aware of increased human USUV infections. The study was published on April 6, 2017, in the journal Eurosurveillance.
Latest Molecular Diagnostics News
- Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
- Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
- Novel Autoantibody Against DAGLA Discovered in Cerebellitis
- Blood Test Could Identify Patients at Risk for Severe Scleroderma
- Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
- Rapid Blood Test Identifies Pre-Symptomatic Patients with Parkinson’s Disease
- Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy
- RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
- First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
- Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
- Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes
- Blood Test Rules Out Future Dementia Risk
- D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
- New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
- Chemiluminescence Immunoassays Support Diagnosis of Alzheimer’s Disease
- Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more